Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 7Unknown 2Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1

Conditions

Non-Erosive Reflux Disease 1Gastroesophageal Reflux 1Colorectal Neoplasms 1Barrett Esophagus 1

Interventions

Oxaliplatin 288Capecitabine 218Fluorouracil 212Irinotecan 145Leucovorin 139Gemcitabine 124S 1 (combination) 110apatinib 109Cisplatin 102Drug Therapy 98Bevacizumab 98Radiotherapy 97Paclitaxel 97camrelizumab 89sintilimab 79Cetuximab 75lenvatinib 62Neoadjuvant Therapy 61tislelizumab 55Surgical Procedures, Operative 54Sorafenib 53Folfox protocol 53toripalimab 52Docetaxel 52130-nm albumin-bound paclitaxel 47Laparoscopy 41HMPL-013 40XELOX 39Radiosurgery 36Albumin-Bound Paclitaxel 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Rabeprazole × Gastrointestinal × Clear all
NCT03260179 2017-08-24

Study to Evaluate the Safety, Preliminary Efficacy and Pharmacokinetics of 3810

Haihe Biopharma Co., Ltd.

Phase 1 Unknown
60 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02149914 2014-11-20

The Changes of Ryodoraku and HRV After PPI Treatment in GERD Patients

Taichung Tzu Chi Hospital

Phase NA Unknown
120 enrolled
Gastrointestinal

Non-Erosive Reflux Disease, Barrett Esophagus, Gastroesophageal Reflux

Data powered by HemOnc (CC BY 4.0) Colophon âš¡